Rainbow Coral Corp. (RBCC) Pursues Expansion and Explores New Funding
Rainbow Coral Corp. today told investors that it is considering new funding opportunities with promise in order to expand in the $232 billion personalized medicine market. The company is pushing forward with its aggressive expansion strategy for this year and is already poised for rapid growth. The company recently signed a joint venture agreement with TheraKine Ltd., the developer of a revolutionary, sustained-release drug delivery platform that could soon make local delivery of biologic agents and small molecules safer, more effective, and more convenient than ever before, and is currently in negotiations to partner with an emerging innovator in the…